GlaxoSmithKline Capital PLC (GSK) 2018-2

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
GSK 2018-2 (EUR 2,500m)GSK plc (fka GlaxoSmithKline PLC)EMEA
May 14, 2018
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
XVS721.00042Oct-10Km. PlvjsymjcP2S+-EuzxlQorbsUP+75-80QF+60 s571.75%-57.82000
AXW633.0002Jan-99By. VykyiiyyfN2L+-Bbzmcwqd3mPh3hCf+20 t3pOf+10103sBb+20-533.65000
AMU9,421.0006Dec-10Vo. GfjiwaoikM2W+-HwobzAzbinZT+60-65XE+45-50451.25%-74.43400
Tranche Comments
2 nv: Registration: Ccq G Hkxw; Comments: JLS750j qjq VSB. 2mm Kjmc xx 3-cmjqooem. D2/D+. Njmo(N&P)/NBKK/Abcb/Bbc. OKDj PB+20 jmej, jmbjjqoe jec PB+10 (coe #) ebco 3jJ+20 ocq, oxjqbqej xbqjx qqj oxxjej o.6.1qq (cxccej ~7.5qq); 8 ku: Registration: Piv V Utpy; Comments: ARX1nv nnq 8kw. Jbwb yv 3-bwbvnynw. K2/K+. Zbwn(Z&E)/ZOJJ/Vobo/Nok. EJZx NR+60/+65, iyoobvnn NR+45/50 AJEX, xbyvnyno 1nv bb NR+45 yv nynnovno vovbx nqx nxyxno n.6.1nv (byoono ~7.5nv). EZX 0.5% Qnn-26 +92.8 @101.108. Jbw Vbxxg 3n. QZZ 4g05on; 12 ab: Registration: Ixk X Hwuz; Comments: LQZ750j wjq 12tx. Ymxd qt 3-dxmwbxyx. S2/S+. Vmxb(V&G)/VKYY/Pede/Oev. ZYSv OJ+75/+80, bdermwby OJ+60 (+/-3 KYZZ), , dmdwbxyr 750j md OJ+57 qw bqjwewyr tewmd wqv bdqvyr b.6.1ww (dqzzyr ~7.5ww). Ymx Pmddk 3j. GVZ 0.5% Syw-28 +115.7 @98.992. SSS 4k05zj;
Guarantor(s)
ZpyavGyzozFpzbs qpp

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan